Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-HIV ribozymes

L Q Sun1, J A Ely, W Gerlach

  • 1Johnson & Johnson Research Laboratories, Sydney NSW, Australia.

Molecular Biotechnology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiometer calibration using machine learning.

Scientific reports·2025
Same author

[Fetoscopy for intrauterine diagnosis and treatment of amniotic band syndrome: a clinical analysis of 7 cases and literature review].

Zhonghua fu chan ke za zhi·2024
Same author

[Association of urinary sodium excretion with fluid overload in patients with chronic kidney disease].

Zhonghua yi xue za zhi·2021
Same author

Barriers to early diagnosis and treatment of severely immunosuppressed patients with HIV-1 infection: A quantitative and qualitative study.

HIV medicine·2020
Same author

A novel v-erb-B-transformed cell-line co-expressing lymphoid and myeloid surface-markers.

International journal of oncology·2011
Same author

Transformation by v-erb-B - induction of apoptosis is abrogated in a myeloid cell-line.

International journal of oncology·2011
Same journal

Applications of Recombinant DNA Technology in Medicine: A Comprehensive Review.

Molecular biotechnology·2026
Same journal

Optimizing miRNA Loading into Platelet Exosomes via Electroporation: A Comparative Analysis of Buffer Systems and Voltage Parameters for Enhanced Targeted Drug Delivery.

Molecular biotechnology·2026
Same journal

Regulation of Goat Milk Protein Synthesis: Genetic Architecture, Signalling Pathways, and Omics Insights.

Molecular biotechnology·2026
Same journal

Cloning and Functional Characterization of AhyAP-T65Lig, an ATP-Dependent DNA Ligase from Trabzonvirus AP-T65.

Molecular biotechnology·2026
Same journal

Overexpression of the ATP-Citrate Lyase Gene Enhances Ganoderic Acid Biosynthesis in Ganoderma lingzhi.

Molecular biotechnology·2026
Same journal

CRISPR/Cas9 Mediated Genome Editing for Enhancing Abiotic Stress Tolerance in Rice: An Omics Guided Perspective.

Molecular biotechnology·2026
See all related articles

Ribozymes, or catalytic RNA molecules, show promise in suppressing Human Immunodeficiency Virus (HIV) replication. This gene therapy approach may complement drug treatments, potentially restoring immune function, with clinical trials planned.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Human Immunodeficiency Virus (HIV) is an RNA virus that replicates using intracellular RNA intermediates.
  • Ribozymes are catalytic RNA molecules with the potential to target viral RNA.
  • Previous research has demonstrated ribozymes' ability to suppress HIV replication.

Purpose of the Study:

  • To explore ribozymes as a gene therapy approach for HIV.
  • To evaluate ribozymes as an adjunct to traditional chemotherapeutic drugs.
  • To assess the potential for viral suppression and immune restoration in HIV patients.

Main Methods:

  • Targeting specific HIV RNA intermediates with ribozymes.
  • Investigating the mechanism of ribozyme-mediated HIV suppression.

Related Experiment Videos

  • Designing and planning clinical trials to test ribozyme efficacy.

    • Main Results:

    • Demonstrated ability of ribozymes to suppress HIV replication in vitro.
    • Theoretical potential for ribozymes to act as an adjunct therapy.
    • Identification of key RNA targets for ribozyme intervention.

    Conclusions:

    • Ribozyme-based gene therapy offers a novel strategy for HIV treatment.
    • This approach may lead to both viral load reduction and immune system recovery.
    • Clinical trials are necessary to validate the therapeutic potential of ribozymes against HIV.